Billion-dollar deal gives Zealand Pharma huge H1 profit

Zealand Pharma, a Danish biotech company, reports a major improvement in its operating profit, reaching 8.1 billion kroner in the first half of the year compared to a loss of 524 million kroner in the same period last year. This surge is attributed to a deal made in March with Swiss company...